Swiss medicine regulator warns against purchase of fake Ozempic
Ozempic is approved in Switzerland for people with type-2 diabetes and can be used as "off label" for weight loss.
Copyright 2023 The Associated Press. All Rights Reserved.
Swissmedic has warned against buying drugs from unreliable sources, particularly from abroad, after reports of hospitalisations in connection with falsified injectables of Ozempic. The medicine, which is approved to treat type 2 diabetes, has been touted as a weight-loss drug on social media.
This content was published on
2 minutes
swissinfo.ch/jdp
The individuals affected were admitted to hospital with acute hypoglycaemia (low blood sugar levels). In one case, an insulin pen had been packaged as an Ozempic pen. Hypoglycaemia triggered by an insulin overdose is life-threatening and must be treated immediately, wroteExternal link the Swiss drugs regulator.
Ozempic is authorised in Switzerland for type 2 diabetes, which is adult-onset diabetes. The drug, developed by the Danish company Novo Nordisk, can be used for weight loss if prescribed by a doctor for “off-label use”. In such a case, the drug must be used under medical supervision.
The active ingredient in Ozempic, semaglutide, is used at a higher dose in another drug, Wegovy, which Swissmedic has authorised for the treatment of obesity.
Semaglutide lowers blood sugar levels and regulates insulin, which is crucial for people with type 2 diabetes. It also imitates a hormone called GLP-1, which can suppress appetite.
Demand for Ozempic skyrocketed after several celebrities and TikTok influencers touted the drug – which is administered as a self-injectable pen – as a way to lose weight in a short time. Due to high demand, falsifications of these products are increasingly appearing internationally, indicated the regulator.
Swissmedic said it “urgently warns against purchasing and using unathorised medicines offered in printed advertisements, promotional e-mails or via websites.”
Popular Stories
More
Foreign affairs
Magnitsky case: How Switzerland failed to investigate Russian millions
What do you think Switzerland’s Alain Berset can bring to the Council of Europe?
The former interior minister is to become the first Swiss Secretary General of the Council of Europe – which issues should his five-year term focus on?
This content was published on
The Swiss army has deployed troops to the Upper Valais village of Saas-Grund, an area of which was buried over the weekend by mudslides.
Initiative for Switzerland to back nuclear weapon ban launched
This content was published on
The Alliance for a Nuclear Weapons Ban has launched a popular initiative for Switzerland to join the UN Treaty on the Prohibition of Nuclear Weapons.
Swiss film director faces backlash over AI-written screenplay
This content was published on
Complaints from film fans over the use of AI has led Prince Charles Cinema in London to cancel the premiere of The Last Screenwriter.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Novartis sets sights on high-value medicines and US market
This content was published on
Swiss pharma giant Novartis has unveiled an updated strategy focused on high-value medicines and boosting its position in the US market.
Swiss alliance calls for obesity to be recognised as a disease
This content was published on
The Swiss Obesity Alliance wants to classify obesity as a disease in the revision of the national strategy on “non-communicable diseases”.
This content was published on
Swiss experts have stepped up their warnings about slimming aids bought over the internet. Some have shown a high level of the potentially fatal substance.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.